Načítá se...
Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomes
Bronchodilators are central to the management of chronic obstructive pulmonary disease (COPD). Clinical studies combining different classes of bronchodilators, in particular a long-acting muscarinic antagonist (LAMA) and a long-acting β(2)-agonist (LABA), have demonstrated greater improvements in lu...
Uloženo v:
| Vydáno v: | Prim Care Respir J |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6547888/ https://ncbi.nlm.nih.gov/pubmed/22222945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4104/pcrj.2011.00102 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|